Bioavailable compositions of amorphous alpha-(N-sulfonamido)acetamide compound

Details for Australian Patent Application No. 2010236701 (hide)

Owner Bristol-Myers Squibb Company

Inventors Hartley, Ruiling F.; Haddadin, Raja M.; Qian, Feng

Agent A J Park

Pub. Number AU-A-2010236701

PCT Pub. Number WO2010/120662

Priority 61/169,066 14.04.09 US

Filing date 12 April 2010

Wipo publication date 21 October 2010

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 31/00 (2006.01)

Event Publications

20 October 2011 PCT application entered the National Phase

  PCT publication WO2010/120662 Priority application(s): WO2010/120662

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010236702-Pressure relief device having support member with recessed areas

2010236700-Bleached dextrin and methods of forming the same